ID

39028

Beschreibung

Study of Effectiveness of Liraglutide Added to High Dose Insulin in Type II Diabetics; ODM derived from: https://clinicaltrials.gov/show/NCT01654120

Link

https://clinicaltrials.gov/show/NCT01654120

Stichworte

Versionen (1)
  1. 22.11.19 22.11.19 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

22. November 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Diabetes Mellitus, Type II NCT01654120

Englisch

Eligibility Diabetes Mellitus, Type II NCT01654120

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. male and female patients with type 2 diabetes with hba1c from 6.5 to 10% treated with intensive insulin therapy (mdi or csii, including u-500 insulin-treated patients) using > 100 units of insulin, with or without a stable dose of oral insulin sensitizing medications, for at least three months.
Beschreibung

Gender | Diabetes Mellitus, Non-Insulin-Dependent | Hemoglobin A1c measurement | Insulin regime With intensity | Insulin injection Daily Dose Multiple | Continuous subcutaneous infusion of insulin | Humulin insulin | Insulin U/day Quantity | Other Coding

Datentyp

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0011860
UMLS CUI [3]
C0474680
UMLS CUI [4,1]
C0557978
UMLS CUI [4,2]
C0522510
UMLS CUI [5,1]
C0199782
UMLS CUI [5,2]
C2348070
UMLS CUI [5,3]
C0439064
UMLS CUI [6]
C0393124
UMLS CUI [7]
C0020171
UMLS CUI [8,1]
C0021641
UMLS CUI [8,2]
C0456683
UMLS CUI [8,3]
C1265611
UMLS CUI [9]
C3846158
2. aged 18 to 80 years.
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
3. females of child-bearing potential must be using adequate form of contraception.
Beschreibung

Childbearing Potential Contraceptive methods

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0700589
4. patient willing to monitor bg four times daily, use cgm, and comply with study-related protocol.
Beschreibung

Blood Glucose Self-Monitoring times/day | Continuous glucose monitoring | Protocol Compliance

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0005803
UMLS CUI [1,2]
C0439511
UMLS CUI [2]
C4523945
UMLS CUI [3]
C0525058
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. type 1 diabetes.
Beschreibung

Diabetes Mellitus, Insulin-Dependent

Datentyp

boolean

Alias
UMLS CUI [1]
C0011854
2. use of any glp-1 receptor agonist within previous three months.
Beschreibung

GLP-1 Receptor Agonist

Datentyp

boolean

Alias
UMLS CUI [1]
C2917359
3. use of dpp-4 inhibitors or oral insulin secretagogues within the previous three months.
Beschreibung

Dipeptidyl Peptidase 4 Inhibitors | Pills Releasing Insulin

Datentyp

boolean

Alias
UMLS CUI [1]
C2917254
UMLS CUI [2,1]
C0994475
UMLS CUI [2,2]
C1283071
UMLS CUI [2,3]
C0021641
4. use of glucocorticoids (except inhaled).
Beschreibung

Glucocorticoids | Exception Glucocorticoids by Inhalation

Datentyp

boolean

Alias
UMLS CUI [1]
C0017710
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0017710
UMLS CUI [2,3]
C0205535
5. use of any experimental drug within previous three months.
Beschreibung

Investigational New Drugs

Datentyp

boolean

Alias
UMLS CUI [1]
C0013230
6. known or suspected allergy to liraglutide, novolog or levemir.
Beschreibung

Hypersensitivity Liraglutide | Hypersensitivity NovoLog | Hypersensitivity Levemir | Hypersensitivity Suspected Liraglutide | Hypersensitivity Suspected NovoLog | Hypersensitivity Suspected Levemir

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C1456408
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0939412
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C1314782
UMLS CUI [4,1]
C0020517
UMLS CUI [4,2]
C0750491
UMLS CUI [4,3]
C1456408
UMLS CUI [5,1]
C0020517
UMLS CUI [5,2]
C0750491
UMLS CUI [5,3]
C0939412
UMLS CUI [6,1]
C0020517
UMLS CUI [6,2]
C0750491
UMLS CUI [6,3]
C1314782
7. personal or family history of medullary carcinoma of the thyroid or men-2.
Beschreibung

Medullary carcinoma of thyroid | Familial medullary thyroid carcinoma | Multiple Endocrine Neoplasia Type | Family history of multiple endocrine neoplasia Type

Datentyp

boolean

Alias
UMLS CUI [1]
C0238462
UMLS CUI [2]
C1833921
UMLS CUI [3,1]
C0027662
UMLS CUI [3,2]
C0332307
UMLS CUI [4,1]
C4039247
UMLS CUI [4,2]
C0332307
8. concomitant chronic renal disease with creatinine > 1.5%.
Beschreibung

Chronic Kidney Disease | Creatinine measurement, serum

Datentyp

boolean

Alias
UMLS CUI [1]
C1561643
UMLS CUI [2]
C0201976
9. concomitant chronic hepatic, gastrointestinal or other illness (including pancreatitis or active cardiovascular disease except stable exertional angina).
Beschreibung

Chronic liver disease | Gastrointestinal Disease chronic | Chronic disease | Pancreatitis | Cardiovascular Disease | Exception Exercise-induced angina Stable

Datentyp

boolean

Alias
UMLS CUI [1]
C0341439
UMLS CUI [2,1]
C0017178
UMLS CUI [2,2]
C0205191
UMLS CUI [3]
C0008679
UMLS CUI [4]
C0030305
UMLS CUI [5]
C0007222
UMLS CUI [6,1]
C1705847
UMLS CUI [6,2]
C0577698
UMLS CUI [6,3]
C0205360
10. inability or unwillingness to monitor bg, use cgm, or comply with study protocol.
Beschreibung

Blood Glucose Self-Monitoring Unable | Continuous glucose monitoring Unable | Protocol Compliance Unable | Blood Glucose Self-Monitoring Unwilling | Continuous glucose monitoring Unwilling | Protocol Compliance Unwilling

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0005803
UMLS CUI [1,2]
C1299582
UMLS CUI [2,1]
C4523945
UMLS CUI [2,2]
C1299582
UMLS CUI [3,1]
C0525058
UMLS CUI [3,2]
C1299582
UMLS CUI [4,1]
C0005803
UMLS CUI [4,2]
C0558080
UMLS CUI [5,1]
C4523945
UMLS CUI [5,2]
C0558080
UMLS CUI [6,1]
C0525058
UMLS CUI [6,2]
C0558080
11. women of child-bearing potential unwilling to use adequate contraception, intending to become pregnant or breast-feeding.
Beschreibung

Childbearing Potential Contraceptive methods Unwilling | Pregnancy intended | Breast Feeding

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0700589
UMLS CUI [1,3]
C0558080
UMLS CUI [2,1]
C0032961
UMLS CUI [2,2]
C1283828
UMLS CUI [3]
C0006147
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Diabetes Mellitus, Type II NCT01654120

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Gender | Diabetes Mellitus, Non-Insulin-Dependent | Hemoglobin A1c measurement | Insulin regime With intensity | Insulin injection Daily Dose Multiple | Continuous subcutaneous infusion of insulin | Humulin insulin | Insulin U/day Quantity | Other Coding
Item
1. male and female patients with type 2 diabetes with hba1c from 6.5 to 10% treated with intensive insulin therapy (mdi or csii, including u-500 insulin-treated patients) using > 100 units of insulin, with or without a stable dose of oral insulin sensitizing medications, for at least three months.
boolean
C0079399 (UMLS CUI [1])
C0011860 (UMLS CUI [2])
C0474680 (UMLS CUI [3])
C0557978 (UMLS CUI [4,1])
C0522510 (UMLS CUI [4,2])
C0199782 (UMLS CUI [5,1])
C2348070 (UMLS CUI [5,2])
C0439064 (UMLS CUI [5,3])
C0393124 (UMLS CUI [6])
C0020171 (UMLS CUI [7])
C0021641 (UMLS CUI [8,1])
C0456683 (UMLS CUI [8,2])
C1265611 (UMLS CUI [8,3])
C3846158 (UMLS CUI [9])
Age
Item
2. aged 18 to 80 years.
boolean
C0001779 (UMLS CUI [1])
Childbearing Potential Contraceptive methods
Item
3. females of child-bearing potential must be using adequate form of contraception.
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Blood Glucose Self-Monitoring times/day | Continuous glucose monitoring | Protocol Compliance
Item
4. patient willing to monitor bg four times daily, use cgm, and comply with study-related protocol.
boolean
C0005803 (UMLS CUI [1,1])
C0439511 (UMLS CUI [1,2])
C4523945 (UMLS CUI [2])
C0525058 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
Diabetes Mellitus, Insulin-Dependent
Item
1. type 1 diabetes.
boolean
C0011854 (UMLS CUI [1])
GLP-1 Receptor Agonist
Item
2. use of any glp-1 receptor agonist within previous three months.
boolean
C2917359 (UMLS CUI [1])
Dipeptidyl Peptidase 4 Inhibitors | Pills Releasing Insulin
Item
3. use of dpp-4 inhibitors or oral insulin secretagogues within the previous three months.
boolean
C2917254 (UMLS CUI [1])
C0994475 (UMLS CUI [2,1])
C1283071 (UMLS CUI [2,2])
C0021641 (UMLS CUI [2,3])
Glucocorticoids | Exception Glucocorticoids by Inhalation
Item
4. use of glucocorticoids (except inhaled).
boolean
C0017710 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0017710 (UMLS CUI [2,2])
C0205535 (UMLS CUI [2,3])
Investigational New Drugs
Item
5. use of any experimental drug within previous three months.
boolean
C0013230 (UMLS CUI [1])
Hypersensitivity Liraglutide | Hypersensitivity NovoLog | Hypersensitivity Levemir | Hypersensitivity Suspected Liraglutide | Hypersensitivity Suspected NovoLog | Hypersensitivity Suspected Levemir
Item
6. known or suspected allergy to liraglutide, novolog or levemir.
boolean
C0020517 (UMLS CUI [1,1])
C1456408 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0939412 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C1314782 (UMLS CUI [3,2])
C0020517 (UMLS CUI [4,1])
C0750491 (UMLS CUI [4,2])
C1456408 (UMLS CUI [4,3])
C0020517 (UMLS CUI [5,1])
C0750491 (UMLS CUI [5,2])
C0939412 (UMLS CUI [5,3])
C0020517 (UMLS CUI [6,1])
C0750491 (UMLS CUI [6,2])
C1314782 (UMLS CUI [6,3])
Medullary carcinoma of thyroid | Familial medullary thyroid carcinoma | Multiple Endocrine Neoplasia Type | Family history of multiple endocrine neoplasia Type
Item
7. personal or family history of medullary carcinoma of the thyroid or men-2.
boolean
C0238462 (UMLS CUI [1])
C1833921 (UMLS CUI [2])
C0027662 (UMLS CUI [3,1])
C0332307 (UMLS CUI [3,2])
C4039247 (UMLS CUI [4,1])
C0332307 (UMLS CUI [4,2])
Chronic Kidney Disease | Creatinine measurement, serum
Item
8. concomitant chronic renal disease with creatinine > 1.5%.
boolean
C1561643 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
Chronic liver disease | Gastrointestinal Disease chronic | Chronic disease | Pancreatitis | Cardiovascular Disease | Exception Exercise-induced angina Stable
Item
9. concomitant chronic hepatic, gastrointestinal or other illness (including pancreatitis or active cardiovascular disease except stable exertional angina).
boolean
C0341439 (UMLS CUI [1])
C0017178 (UMLS CUI [2,1])
C0205191 (UMLS CUI [2,2])
C0008679 (UMLS CUI [3])
C0030305 (UMLS CUI [4])
C0007222 (UMLS CUI [5])
C1705847 (UMLS CUI [6,1])
C0577698 (UMLS CUI [6,2])
C0205360 (UMLS CUI [6,3])
Blood Glucose Self-Monitoring Unable | Continuous glucose monitoring Unable | Protocol Compliance Unable | Blood Glucose Self-Monitoring Unwilling | Continuous glucose monitoring Unwilling | Protocol Compliance Unwilling
Item
10. inability or unwillingness to monitor bg, use cgm, or comply with study protocol.
boolean
C0005803 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
C4523945 (UMLS CUI [2,1])
C1299582 (UMLS CUI [2,2])
C0525058 (UMLS CUI [3,1])
C1299582 (UMLS CUI [3,2])
C0005803 (UMLS CUI [4,1])
C0558080 (UMLS CUI [4,2])
C4523945 (UMLS CUI [5,1])
C0558080 (UMLS CUI [5,2])
C0525058 (UMLS CUI [6,1])
C0558080 (UMLS CUI [6,2])
Childbearing Potential Contraceptive methods Unwilling | Pregnancy intended | Breast Feeding
Item
11. women of child-bearing potential unwilling to use adequate contraception, intending to become pregnant or breast-feeding.
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0558080 (UMLS CUI [1,3])
C0032961 (UMLS CUI [2,1])
C1283828 (UMLS CUI [2,2])
C0006147 (UMLS CUI [3])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video